Literature DB >> 8015553

Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma.

B Gellersen1, R Kempf, R Telgmann, G E DiMattia.   

Abstract

Expression of the human PRL (hPRL) gene in extrapituitary sites such as the uterus (decidualized endometrial stroma and myometrium) and cells of the hematopoietic lineage is directed by an alternative promoter which is located approximately 6 kilobases (kb) upstream of the pituitary-specific start site. In order to delineate the tissue-specific mechanisms governing the control of nonpituitary PRL gene expression, we have cloned and sequenced 3 kb 5'-flanking DNA of the upstream decidual/lymphoid (dPRL) promoter. Based on sequence homology we identified two binding motifs for Pit-1 and seven half-sites for glucocorticoid receptor/progesterone receptor (PR) binding. We focused our studies on the role of Pit-1 and of PR as potential transcriptional regulators, since the POU domain protein Pit-1 is essential in the control of pituitary PRL expression, and progesterone induces decidual transformation of the endometrial stroma, a differentiation process during which the decidual PRL gene is activated. We demonstrate in a variety of cell types, including lymphocytes and endometrial stroma, that Pit-1 is not involved in the regulation of dPRL promoter/reporter gene constructs carrying 3 kb 5'-flanking DNA. Our experiments also show that activated PR does not confer direct transcriptional control on the dPRL promoter. When we compared the activity of the transfected dPRL promoter in PRL-secreting and nonsecreting lymphoid cells, we found that the 3 kb 5'-flanking region of the dPRL promoter did not contain elements restricting expression to only those lymphocytes that produce PRL but allowed expression of fusion reporter genes irrespective of the status of the endogenous PRL gene. This was in sharp contrast to endometrial cells where 3 kb 5'-flanking DNA conferred strong transcriptional activation on the dPRL promoter in decidualized endometrial stromal cells actively secreting PRL, but did not allow transcription in undifferentiated non-PRL-secreting endometrial stromal cells. Activation of the dPRL promoter construct in these undifferentiated cells could however be induced by the addition of cAMP, in the absence of progesterone, suggesting that a signal transduced through the cAMP signaling pathway is a primary inducer of decidual PRL gene expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8015553     DOI: 10.1210/mend.8.3.8015553

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  51 in total

1.  Completely humanizing prolactin rescues infertility in prolactin knockout mice and leads to human prolactin expression in extrapituitary mouse tissues.

Authors:  Heather R Christensen; Michael K Murawsky; Nelson D Horseman; Tara A Willson; Karen A Gregerson
Journal:  Endocrinology       Date:  2013-09-12       Impact factor: 4.736

2.  Expression of the metastasis suppressor KAI1 in decidual cells at the human maternal-fetal interface: Regulation and functional implications.

Authors:  Birgit Gellersen; Juliane Briese; Marine Oberndörfer; Katja Redlin; Annemarie Samalecos; Dagmar-Ulrike Richter; Thomas Löning; Heinrich-Maria Schulte; Ana-Maria Bamberger
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Extrapituitary prolactin promoter polymorphism in Czech patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Markéta Fojtíková; Marie Cerná; Pavlína Cejková; Sárka Ruzicková; Ctibor Dostál
Journal:  Ann Rheum Dis       Date:  2007-05       Impact factor: 19.103

4.  Polymorphism of the prolactin extrapituitary promoter in psoriatic arthritis.

Authors:  Jirí Stolfa; Markéta Fojtíková; Pavlína Cejková; Marie Cerná; Liliana Sedová; Ctibor Dostál
Journal:  Rheumatol Int       Date:  2007-06-13       Impact factor: 2.631

5.  Down-regulation of the histone methyltransferase EZH2 contributes to the epigenetic programming of decidualizing human endometrial stromal cells.

Authors:  Giulia Grimaldi; Mark Christian; Jennifer H Steel; Patrick Henriet; Matti Poutanen; Jan J Brosens
Journal:  Mol Endocrinol       Date:  2011-09-08

6.  Polymorphism of the extrapituitary prolactin promoter and systemic sclerosis.

Authors:  Markéta Fojtíková; Pavlína Cejková; Radim Bečvář; Jiří Vencovský; Jana Tomasová Studýnková; Marie Cerná
Journal:  Rheumatol Int       Date:  2009-12-19       Impact factor: 2.631

Review 7.  Minireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions.

Authors:  Robert J Marano; Nira Ben-Jonathan
Journal:  Mol Endocrinol       Date:  2014-04-02

8.  Multiple cAMP-induced signaling cascades regulate prolactin expression in T cells.

Authors:  S Gerlo; P Verdood; E L Hooghe-Peters; R Kooijman
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

9.  Characterization of a novel telomerase-immortalized human endometrial stromal cell line, St-T1b.

Authors:  Annemarie Samalecos; Katja Reimann; Stefanie Wittmann; Heinrich M Schulte; Jan J Brosens; Ana-Maria Bamberger; Birgit Gellersen
Journal:  Reprod Biol Endocrinol       Date:  2009-07-20       Impact factor: 5.211

10.  The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors.

Authors:  I Ben-Batalla; S Seoane; M Macia; T Garcia-Caballero; L O Gonzalez; F Vizoso; R Perez-Fernandez
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.